Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion
Graefe's Archive for Clinical and Experimental Ophthalmology · 2024
DOI: 10.1007/s00417-024-06410-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, 2024. Verfasst von Peyman Razavi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Retinal Imaging Lab, Boston, MA, USA. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Ranibizumab, Retinal Vein Occlusion, Tomography, Optical Coherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Lions International Fund.
Abstract (Originalsprache)
PURPOSE: To investigate the impact of anti-VEGF therapy on vascular metrics in eyes with macular edema secondary to central retinal vein occlusion (CRVO) using wider field swept-source OCT angiography (WF SS-OCTA). METHODS: We included 23 eyes with macular edema associated with non-ischemic CRVO from 22 patients treated with anti-VEGF therapy (median number of injections: 5 [2-9]). Changes in vessel density (VD), vessel skeletonized density (VSD), and foveal avascular zone (FAZ) parameters were measured using WF SS-OCTA. Visual acuity (VA) and central subfield thickness (CST) were also measured. RESULTS: Median CST decreased significantly from 369 µm (305-531) to 267 µm (243-300, p < 0.001). VD and VSD parameters in 12 × 12 mm images showed significant reductions. For instance, VSD in the whole retina decreased from a median of 13.37 (11.22-13.74) to 11.29 (9.36-12.97, p = 0.013). Additionally, a significant increase in FAZ circularity was found, suggesting improved microvascular integrity. Significant inverse correlations were found between the number of anti-VEGF injections and all VSD and VD parameters on the 12 × 12 mm images (p < 0.05). Notably, the reductions in VSD and VD on 12 × 12 mm angiograms in the deep capillary plexus (DCP) after each injection significantly correlated with increased logMAR VA (worse VA). CONCLUSION: Anti-VEGF therapy in CRVO patients not only mitigates macular edema but also alters the overall microvascular morphology and functionality as revealed by WF SS-OCTA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Retinal Imaging Lab, Boston, MA, USA.
- Retina Service, Massachusetts Eye and Ear, Boston, MA, USA.
- Harvard Retinal Imaging Lab, Boston, MA, USA. John_Miller@meei.harvard.edu.
- Retina Service, Massachusetts Eye and Ear, Boston, MA, USA. John_Miller@meei.harvard.edu.
- Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Retinal Imaging Lab, Harvard Medical School, 243 Charles St., Boston, MA, 02114, USA. John_Miller@meei.harvard.edu.
Förderung
- Lions International Fund
Zitieren
APA
Razavi, P., Baldwin, G., Garg, I., Velazquez, L. M., Garcia, M., Gan, J., Choi, H., Zeng, R., Vingopoulos, F., Husain, D., Kim, L. A., Patel, N. A., & Miller, J. B. (2024). Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-024-06410-3
Vancouver
Razavi P, Baldwin G, Garg I, Velazquez LM, Garcia M, Gan J, et al. Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology. 2024. doi:10.1007/s00417-024-06410-3
BibTeX
@article{Razavi2024,
author = {Razavi, Peyman and Baldwin, Grace and Garg, Itika and Velazquez, Luis Martinez and Garcia, Mauricio and Gan, Jenny and Choi, Hanna and Zeng, Rebecca and Vingopoulos, Filippos and Husain, Deeba and Kim, Leo A and Patel, Nimesh A and Miller, John B},
title = {Changes in wider field swept-source OCT angiography vascular metrics with anti-vascular endothelial growth factor therapy in central retinal vein occlusion},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2024},
doi = {10.1007/s00417-024-06410-3}
}
EUVIMED